Cardiovascular disease has overtaken AIDS-related illnesses as the leading cause of death among people living with HIV aged 45 and older over the past 25 years.
For decades, opportunistic infections and malignancies defined the clinical reality of an HIV diagnosis. Modern antiretroviral therapy has successfully suppressed viral loads and extended lifespans, shifting the primary medical challenge toward chronic age-related comorbidities.
Researchers presented new data at IDWeek 2026 showing that deaths attributable to cardiovascular conditions now surpass those caused directly by AIDS. While opportunistic illnesses remain a clinical concern, aging cohorts face substantially elevated baseline risks for metabolic and vascular complications compared to the general population.
Chronic systemic inflammation, persistent immune activation, and metabolic side effects from certain antiretroviral agents accelerate vascular aging and atherosclerosis.
- Shift in Mortality: Heart disease is now a more frequent cause of death than AIDS-related conditions for people with HIV over 45.
- Earlier Onset: Comorbidities such as cardiovascular disease tend to manifest earlier in HIV-positive individuals than in the general population.
- Holistic Care Models: Modern treatment requires integrating routine cardiovascular risk screening alongside ongoing viral suppression therapy.
Clinical data from recent epidemiological studies highlight the necessity of modifying traditional HIV care paradigms. Antiretroviral regimens successfully manage viral replication, but they do not automatically mitigate cardiovascular disease risk factors such as dyslipidemia and arterial inflammation.
Healthcare providers must incorporate comprehensive lipid panels, blood pressure monitoring, and glycemic assessments into regular clinical evaluations. Clinical trials investigating targeted anti-inflammatory therapies and statin protocols in people with HIV continue to provide critical insights into reducing major adverse cardiac events.
| Clinical Parameter | General Population | HIV-Positive Population |
|---|---|---|
| Primary Cause of Mortality (Age 45+) | Cardiovascular Disease | Cardiovascular Disease |
| Onset Age for Comorbidities | Later Adulthood | Premature / Younger Ages |
| Primary Drivers | Lifestyle, Genetics, Aging | Immune Activation, Inflammation, ART Effects |
Individuals managing HIV who experience persistent fatigue, shortness of breath, chest discomfort, or palpitations must seek prompt evaluation from their primary care physician or infectious disease specialist to rule out acute cardiac involvement.
Physicians evaluating older adults with HIV must carefully review drug-drug interactions between antiretroviral medications and cardiovascular therapeutics, such as statins or antihypertensives, before initiating new interventions.
- IDWeek 2026.
- POZ news story.
Always consult a qualified healthcare provider regarding any clinical questions or treatment modifications.
